retatrutide fda approval status 2024 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide approval: FDA status, clinical
Description
Which in turn leads to weight loss

About 4% of women aged 18-29 who had type 2 diabetes and were on GLP-1 RAs became pregnant, the highest rate among all age groups

The most common drug-related adverse events were nausea, constipation and vomiting

10.1523/JNEUROSCI.3262-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar] During, M

[DOI] [PubMed] [Google Scholar] 241.Kang SM, Kwon HM, Hong BK, Kim D, Kim IJ, Choi EY, et al
For men, t
